Close Menu

NEW YORK (GenomeWeb) – Plexera Biotechnology and JPT Peptide Technologies today announced a deal to distribute JPT's peptide-based products and services in China and to develop peptide-based applications on Plexera's PlexArray HT platform for high-throughput proteomics screening. 

Plexera will distribute JPT's products and services to the Chinese proteomics, immunotherapy, and vaccine markets, the companies said. Financial and other terms of the agreement were not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.